Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Immunopharmacol Immunotoxicol ; 33(4): 730-7, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21457109

RESUMEN

CONTEXT: Research on drug delivery carriers that use nanoparticles is currently attracting a great deal of attention. In order to evaluate the safety of these drug carriers for clinical applications, a full assessment of their toxicity and bioactivity is required. Although it is well-known that the surface charge of nanoparticles influences their bioactivity, most of the published studies on n-butylcyanoacrylate (NBCA) nanoparticles as a potential drug delivery carrier are restricted to analyzing the anionic form. OBJECTIVE: We compared biological responses of cyanoacrylate anionic nanoparticles with cationic nanoparticles in cultured murine macrophages for assessing cytotoxicity and inflammatory responses. MATERIALS AND METHODS: The cytotoxicity was evaluated with the MTS and LDH leakage assays. Inflammatory responses were evaluated by measurement of nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). The interaction of the nanoparticle and the macrophage was assessed by fluorescence microscopy. RESULT: Anionic and cationic NP showed no detectable cytotoxicity at a concentration of 10 µg/mL or less. At concentrations greater than 10 µg/mL, cationic NP displayed lower cytotoxicity by comparison with anionic NP. NO, IL-6, and TNF-α production were not induced by anionic or cationic nanoparticles alone. In contrast, both types of nanoparticles decreased NO, IL-6, and TNF-α productions induced by LPS. However, the anti-inflammatory effect of anionic nanoparticles was significantly greater than that of cationic nanoparticles. Nanoparticles were presumed to be either internalized or attached to the cell membranes. DISCUSSION AND CONCLUSION: NBCA nanoparticles are not only important as potential drug carriers but also as promising anti-inflammatory agents that may have therapeutic properties.


Asunto(s)
Antiinflamatorios/farmacología , Sistemas de Liberación de Medicamentos , Enbucrilato/farmacología , Interleucina-6/inmunología , Macrófagos/inmunología , Nanopartículas , Óxido Nítrico/inmunología , Factor de Necrosis Tumoral alfa/inmunología , Animales , Aniones/farmacología , Cationes/farmacología , Línea Celular , Interleucina-6/biosíntesis , Macrófagos/metabolismo , Ratones , Óxido Nítrico/metabolismo , Factor de Necrosis Tumoral alfa/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA